The term ‘minimal uterine serous carcinoma’ has been proposed to include serous carcinomas with invasion limited to the endometrium (superficial serous carcinoma), and those without stromal ...

Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 cancer. Most uterine cancers have excellent five-year survival rates – up to 95% for localized ...

Uterine serous cancer (USC) is a highly aggressive variant of endometrial cancer. USC is resistant to cytotoxic chemotherapy and is responsible for most recurrences and deaths from endometrial cancer.

This group includes more aggressive cancers like uterine serous carcinoma and clear cell carcinoma. Uterine sarcoma. This rare type forms in the muscle wall of your uterus (myometrium).

Most uterine cancers have excellent five-year survival rates—up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 cancer. Now, researchers at MUSC Hollings Cancer Center say that in the course of developing a ...

Adavosertib demonstrated clinical activity among women with recurrent uterine serous carcinoma, according to results of a phase 2 study published in Journal of Clinical Oncology.“Uterine serous ...

Most uterine cancers have excellent five-year survival rates -- up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

Learn about metastatic endometrial cancer symptoms, treatment options, ... This is more common with aggressive endometrial cancers like serous and clear cell adenocarcinomas.

Elevated levels of the protein, also referred to as Gal3, has also been associated with worse outcomes for patients with uterine serous cancer — a more aggressive type of uterine cancer, which ...

Background: Uterine serous carcinoma (USC) is a rare and deadly form of endometrial cancer. It is unclear whether BRCA1 pathogenic variants (PV) are associated with an increased risk of USC. Because ...

Uterine serous cancer constitutes up to 10% of all endometrial tumors, and represents the most biologically aggressive variant of type II EC.